HR+/HER2- Breast Cancer Market

HR-positive/ HER2-negative breast cancer is the most common form of breast cancer. This type accounts for a higher percentage among all breast cancers. Hormone receptors are proteins that receive hormone signals and tell the cancer cells to grow. If breast cancer cells get signals from the hormone estrogen that could promote tumor growth, it is known as estrogen receptor-positive (ER+) breast cancer.

109 views
0 faves
0 comments
Uploaded on February 24, 2020